UNITED GUARDIAN INC
United Guardian manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, as well as healthcare products including pharmaceuticals and medical lubricants. It operates as a single business segment with four product categories: cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness ingredients. Its product lines include Lubrajel hydrogel formulations for personal care and medical applications, the Natrajel line for sexual wellness, and the Renacidin prescription drug and Clorpactin topical antimicrobial. United Guardian sells cosmetic ingredients to distributors that resell them to personal care and cosmetic product manufacturers. It sells pharmaceuticals primarily through national drug wholesalers, and medical lubricants directly to finished-product marketers or their contract manufacturers. Its sexual wellness ingredients are prepared for distribution through partners. The company conducts research and development to create products and extend existing product lines, and manufactures its products at its facility in Hauppauge, New York, except Renacidin, which is made by a contract manufacturer.
No SEC Form 4 filings for $UG in the last 30 days.
See all $UG insider activity →United-Guardian reported 3Q 2026 revenue of $3.49M, up 54% YoY, with EPS of $0.2. Growth was driven by pharmaceuticals, cosmetic ingredients, and medical lubricants. Pharmaceutical sales rose 29% due to Renacidin formulary coverage, while cosmetic ingredient sales climbed 187% after ASI resumed purchases. Medical lubricant sales increased 20%, and cost of sales fell to 46% of revenue.
UNITED GUARDIAN INC (UG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 United-Guardian Reports Higher Third Quarter Earnings HAUPPAUGE, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the third quarter and first nine months of 2026. Third quarter net sales increased by
Upside Gold Corp. completed 6,563m of diamond drilling in 2026, 64% more than planned. Assays are pending, with an updated resource estimate expected in Q1 2027. The company drilled 24 holes at its Kena project. According to the company, this update builds on a 2021 resource estimate.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning UG (UNITED GUARDIAN INC). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent UG coverage spans financial news and earnings.
Strong top‑line growth and EPS beat suggest positive earnings momentum.
Strong earnings beat likely lift the stock.
Drill completion signals progress on the Kena project; market reaction will depend on upcoming assay results.
The drill expansion signals potential resource growth, likely prompting modest buying interest.
The 8-K discloses a fresh earnings datapoint (sales, net income, EPS) plus segment drivers (cosmetic ingredients up sharply, Renacidin as key pharma growth driver).
AlphAI scores every news story that mentions UG with an AI model for sentiment and relevance, and aggregates insider trades from UNITED GUARDIAN INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
United-Guardian reported 3Q 2026 revenue of $3.49M, up 54% YoY, with EPS of $0.2. Growth was driven by pharmaceuticals, cosmetic ingredients, and medical lubricants. Pharmaceutical sales rose 29% due to Renacidin formulary coverage, while cosmetic ingredient sales climbed 187% after ASI resumed purchases. Medical lubricant sales increased 20%, and cost of sales fell to 46% of revenue.
UNITED GUARDIAN INC (UG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 United-Guardian Reports Higher Third Quarter Earnings HAUPPAUGE, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the third quarter and first nine months of 2026. Third quarter net sales increased by
Upside Gold Corp. completed 6,563m of diamond drilling in 2026, 64% more than planned. Assays are pending, with an updated resource estimate expected in Q1 2027. The company drilled 24 holes at its Kena project. According to the company, this update builds on a 2021 resource estimate.
Upside Gold Corp. plans to expand 2026 drilling at its Kena Gold-Copper Project by 1,000 meters, bringing the total to 6,180 meters. The decision follows core logging that identified additional targets. The company expects assays to confirm economic grades and continuity, potentially supporting a resource update.
UNITED GUARDIAN INC (UG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 United-Guardian Reports Second Quarter Results HAUPPAUGE, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2026. Second quarter net sales increased by 10% from $2,
United-Guardian's Q3 earnings fall y/y on weak cosmetic sales, pressuring margins and sending UG shares down even as pharma and medical lines grow.
Broadcom, Oracle, Cisco Systems, and United-Guardian take center stage in the latest Zacks Analyst Blog with fresh research insights.
United-Guardian's Q2 earnings fall on weak cosmetic sales, partly offset by gains in pharmaceuticals and medical lubricants, with recovery hopes ahead.
United-Guardian ( NASDAQ:UG ) , a specialty ingredients manufacturer known for its pharmaceutical, cosmetic, and medical lubricant products, released its second quarter fiscal 2025 results on August 8, 2025. Alongside net income ( GAAP ) falling to $626,826, as cosmetic ingredient sales dropped ...
UG's Q1 earnings drop 39% as cosmetic sales plunge, offsetting gains in pharmaceuticals and medical lubricants.
